Richard Greil currently works at the University Clinic of Internal Medicine III, Paracelsus Medical University Salzburg/Uniklinikum. He is Head of the Department and Head of the Laboratory of Immunological and Molecular Cancer Research (LIMCR) as well as the Center for Clinical Cancer and Immunology Trials (CCCIT) at the Salzburg Cancer Research Institute (SCRI). In addition, he is Head of the Cancer Cluster Salzburg (CCS) and chairman of the AGMT (Austrian Group of Medical Tumor Therapy). He is also Vice President of the ABCSG. His scientific interests are directed towards the performance of clinical trials in haematology and medical oncology and to research in the pathophysiology of chronic lymphocytic leukemia, non-Hodgkin lymphoma, AML, and breast and head and neck cancer.